Literature DB >> 14963155

In vivo role of nectin-1 in entry of herpes simplex virus type 1 (HSV-1) and HSV-2 through the vaginal mucosa.

Melissa M Linehan1, Susan Richman, Claude Krummenacher, Roselyn J Eisenberg, Gary H Cohen, Akiko Iwasaki.   

Abstract

Herpes simplex virus type 2 (HSV-2) is transmitted through the genital mucosa during sexual encounters. In recent years, HSV-1 has also become commonly associated with primary genital herpes. The mechanism of viral entry of HSV-1 and HSV-2 in the female genital tract is unknown. In order to understand the molecular interactions required for HSV entry into the vaginal epithelium, we examined the expression of herpesvirus entry mediator nectin-1 in the vagina of human and mouse at different stages of their hormonal cycle. Nectin-1 was highly expressed in the epithelium of human vagina throughout the menstrual cycle, whereas the mouse vaginal epithelium expressed nectin-1 only during the stages of the estrous cycle in which mice are susceptible to vaginal HSV infection. Furthermore, the ability of nectin-1 to mediate viral entry following intravaginal inoculation was examined in a mouse model of genital herpes. Vaginal infection with either HSV-1 or HSV-2 was blocked by preincubation of the virus with soluble recombinant nectin-1. Viral entry through the vaginal mucosa was also inhibited by preincubation of HSV-2 with antibody against gD. Together, these results suggest the importance of nectin-1 in mediating viral entry for both HSV-1 and HSV-2 in the genital mucosa in female hosts.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14963155      PMCID: PMC369262          DOI: 10.1128/jvi.78.5.2530-2536.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Herpes simplex virus glycoprotein D can bind to poliovirus receptor-related protein 1 or herpesvirus entry mediator, two structurally unrelated mediators of virus entry.

Authors:  C Krummenacher; A V Nicola; J C Whitbeck; H Lou; W Hou; J D Lambris; R J Geraghty; P G Spear; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

2.  Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family.

Authors:  R I Montgomery; M S Warner; B J Lum; P G Spear
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

3.  Immunohistochemical localization of testin in the female reproductive system of the rat is consistent with its involvement in the turnover of specialized junctional complexes.

Authors:  L Zhu; A Moo-Young; C W Bardin; C Y Cheng
Journal:  Biol Reprod       Date:  1997-05       Impact factor: 4.285

4.  The murine homolog of human Nectin1delta serves as a species nonspecific mediator for entry of human and animal alpha herpesviruses in a pathway independent of a detectable binding to gD.

Authors:  L Menotti; M Lopez; E Avitabile; A Stefan; F Cocchi; J Adelaide; E Lecocq; P Dubreuil; G Campadelli-Fiume
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

5.  A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry.

Authors:  D Shukla; J Liu; P Blaiklock; N W Shworak; X Bai; J D Esko; G H Cohen; R J Eisenberg; R D Rosenberg; P G Spear
Journal:  Cell       Date:  1999-10-01       Impact factor: 41.582

Review 6.  The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells.

Authors:  G Campadelli-Fiume; F Cocchi; L Menotti; M Lopez
Journal:  Rev Med Virol       Date:  2000 Sep-Oct       Impact factor: 6.989

7.  Cervical shedding of herpes simplex virus in human immunodeficiency virus-infected women: effects of hormonal contraception, pregnancy, and vitamin A deficiency.

Authors:  S B Mostad; J K Kreiss; A J Ryncarz; K Mandaliya; B Chohan; J Ndinya-Achola; J J Bwayo; L Corey
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

8.  Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor.

Authors:  R J Geraghty; C Krummenacher; G H Cohen; R J Eisenberg; P G Spear
Journal:  Science       Date:  1998-06-05       Impact factor: 47.728

9.  A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus.

Authors:  M S Warner; R J Geraghty; W M Martinez; R I Montgomery; J C Whitbeck; R Xu; R J Eisenberg; G H Cohen; P G Spear
Journal:  Virology       Date:  1998-06-20       Impact factor: 3.616

10.  Nectin/PRR: an immunoglobulin-like cell adhesion molecule recruited to cadherin-based adherens junctions through interaction with Afadin, a PDZ domain-containing protein.

Authors:  K Takahashi; H Nakanishi; M Miyahara; K Mandai; K Satoh; A Satoh; H Nishioka; J Aoki; A Nomoto; A Mizoguchi; Y Takai
Journal:  J Cell Biol       Date:  1999-05-03       Impact factor: 10.539

View more
  40 in total

1.  Multiple receptor interactions trigger release of membrane and intracellular calcium stores critical for herpes simplex virus entry.

Authors:  Natalia Cheshenko; Wen Liu; Lisa M Satlin; Betsy C Herold
Journal:  Mol Biol Cell       Date:  2007-06-06       Impact factor: 4.138

2.  Early resolution of herpes simplex virus type 2 infection of the murine genital tract involves stimulation of genital parenchymal cells by gamma interferon.

Authors:  Melanie D Bird; Chin-Fun Chu; Alison J Johnson; Gregg N Milligan
Journal:  J Virol       Date:  2006-10-25       Impact factor: 5.103

3.  Rapid clearance of herpes simplex virus type 2 by CD8+ T cells requires high level expression of effector T cell functions.

Authors:  Michelle H Nelson; Melanie D Bird; Chin-Fun Chu; Alison J Johnson; Brian M Friedrich; Windy R Allman; Gregg N Milligan
Journal:  J Reprod Immunol       Date:  2011-03-27       Impact factor: 4.054

4.  B Virus (Macacine herpesvirus 1) Glycoprotein D Is Functional but Dispensable for Virus Entry into Macaque and Human Skin Cells.

Authors:  Ludmila Perelygina; Irina Patrusheva; Mugdha Vasireddi; Nicole Brock; Julia Hilliard
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

5.  Vaginally delivered tenofovir disoproxil fumarate provides greater protection than tenofovir against genital herpes in a murine model of efficacy and safety.

Authors:  Briana Nixon; Thomas Jandl; Ryan S Teller; Ekaterina Taneva; Yanhua Wang; Umadevi Nagaraja; Patrick F Kiser; Betsy C Herold
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191

6.  Long-term presence of virus-specific plasma cells in sensory ganglia and spinal cord following intravaginal inoculation of herpes simplex virus type 2.

Authors:  Gregg N Milligan; Michael G Meador; Chin-Fun Chu; Christal G Young; Talitha L Martin; Nigel Bourne
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords.

Authors:  Alison J Johnson; Chin-Fun Chu; Gregg N Milligan
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

8.  Antibody-mediated protection against genital herpes simplex virus type 2 disease in mice by Fc gamma receptor-dependent and -independent mechanisms.

Authors:  Chin-Fun Chu; Michael G Meador; Christal G Young; Jane E Strasser; Nigel Bourne; Gregg N Milligan
Journal:  J Reprod Immunol       Date:  2007-10-24       Impact factor: 4.054

9.  Herpes simplex virus (HSV)-specific T cells activated in the absence of IFN-gamma express alternative effector functions but are not protective against genital HSV-2 infection.

Authors:  Alison J Johnson; Michelle H Nelson; Melanie D Bird; Chin-Fun Chu; Gregg N Milligan
Journal:  J Reprod Immunol       Date:  2009-11-25       Impact factor: 4.054

Review 10.  Research gaps in defining the biological link between HIV risk and hormonal contraception.

Authors:  Kerry Murphy; Susan C Irvin; Betsy C Herold
Journal:  Am J Reprod Immunol       Date:  2014-02-19       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.